Asian perspectives in the management of inflammatory bowel disease: Findings from a recent survey

Sung, Joseph J.Y.; Kamm, Michael A.; Marteau, Philippe

doi:10.1111/j.1440-1746.2009.06024.x

Cited by 24 publications

(36 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Considering these differences, the IBD management consensus was formulated in the Asia-Pacific region in 2005 and 2010 [2,3]. In addition, there are original diagnostic criteria, guidelines and consensus in China, Korea and Japan, and various differences in the diagnosis and treatment of IBD among East Asian countries [4,5,6,7,8,9]. …”

Section: Introductionmentioning

confidence: 99%

“…A questionnaire-based survey was performed to investigate the state of diagnostic and treatment methods for IBD in East Asia in 2007 [9]. Five years later, the diagnostic and treatment methods for IBD have markedly changed, as described above, and the actual state of the selection of new diagnostic and treatment methods for IBD in East Asia is currently unclear.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A Questionnaire-Based Survey on the Diagnosis and Management of Inflammatory Bowel Disease in East Asian Countries in 2012

et al. 2014

View full text Add to dashboard Cite

Background and Aim: The prevalence and incidence of inflammatory bowel disease (IBD) are lower in East Asia than in Western countries; however, marked increases have recently been reported. The clinical diagnosis and medical management of IBD in East Asia differ from those in Western countries. A questionnaire-based survey was performed to gather physicians' current opinions on IBD in different East Asian countries. Methods: Representative International Gastrointestinal Consensus Symposium (IGICS) committee members provided a questionnaire to physicians in each East Asian country studied. The questionnaire mainly focused on the diagnosis and management of IBD. Results: There were 19 respondents from Japan, 10 from South Korea, 9 from the Philippines, 6 from China and 4 from Indonesia. Colonoscopy (100%) and histopathology (63%) were commonly used for the diagnosis in ulcerative colitis (UC). Conventional small bowel enteroclysis was still the most common diagnostic tool for assessing small bowel lesions in Crohn's disease (CD) in East Asia. The percentage of physicians who investigated the reactivation of Cytomegalovirus in severe or refractory patients with UC ranged from 0% in the Philippines and Indonesia to 100% in Japan and Korea. Most physicians in Korea, the Philippines, China and Indonesia chose thiopurines or anti-TNF therapy as the second-line treatment in severe refractory UC, whereas Japanese physicians preferred to use tacrolimus or leukocyte apheresis. Physicians in the Philippines and Indonesia preferred to use oral 5-aminosalicylic acid for newly diagnosed severe ileocecal CD. In contrast, Korean physicians chose oral steroids and most physicians in China and Japan preferred to use anti-TNF. Nutritional therapy to induce or maintain remission in patients with CD was commonly used in Indonesia, Japan and China. Targeted biopsies by conventional colonoscopy were the most preferred strategy for cancer surveillance in long-standing UC over random biopsies in this region. Conclusions: The present survey found that current diagnostic approaches and clinical management of IBD vary within East Asian countries.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

A Questionnaire-Based Survey on the Diagnosis and Management of Inflammatory Bowel Disease in East Asian Countries in 2012

et al. 2014

View full text Add to dashboard Cite

show abstract

“…On the other hand, smoking cessation is associated with a 65% reduction in the risk of relapse as compared with active smoking, a similar magnitude of improvement to that obtained with IS therapy (17) . Though it is well-known fact that IS therapy are effective for both induction and maintenance of remission in CD (25) , Sung et al found that most physicians in Asia favored the monotherapy of 5-Aminosalicylic acid medication as maintenance therapy of mild-to-moderate CD (36) . Besides the reasons that have been mentioned previously, another possible reason of avoiding using IS therapy might be the concern of its infective risk.…”

Section: Discussionmentioning

confidence: 99%

GENDER-RELATED DIFFERENCES IN CLINICAL COURSE OF CROHN’S DISEASE IN AN ASIAN POPULATION: a retrospective cohort review

Law¹,

Li²

2014

Arq. Gastroenterol.

View full text Add to dashboard Cite

show abstract

“…It is also notable that postoperative pathology-revealed dysplasia/cancer was determined in 21 (23.3%) patients, although only 8 (8.9%) had been diagnosed preoperatively. This could be explained by the fact that physicians in this field tended to regard surgical treatment as a last resort, as reported by Sung et al (31). The patients with UC require a multidisciplinary approach from the gastroenterologist and colorectal surgeon.…”

Section: Discussionmentioning

confidence: 99%

Risk factors for complications after total colectomy in ulcerative colitis

Kim

Park²,

Kang³

et al. 2012

Turk J Gastroenterol

View full text Add to dashboard Cite

Asian perspectives in the management of inflammatory bowel disease: Findings from a recent survey

Abstract: Clinical practice with regards to IBD diagnosis and management varies within Asia.5-ASA is the preferred treatment and maintenance therapy for mild-to-moderate IBD.

Cited by 24 publications

References 47 publications

A Questionnaire-Based Survey on the Diagnosis and Management of Inflammatory Bowel Disease in East Asian Countries in 2012

A Questionnaire-Based Survey on the Diagnosis and Management of Inflammatory Bowel Disease in East Asian Countries in 2012

GENDER-RELATED DIFFERENCES IN CLINICAL COURSE OF CROHN’S DISEASE IN AN ASIAN POPULATION: a retrospective cohort review

Risk factors for complications after total colectomy in ulcerative colitis

Contact Info

Product

Resources

About